AR026030A1 - Un complejo a base de acido ortosilicico biologicamente asimilable, que se presenta bajo una forma solida, estable y concentrada, y un proceso depreparacion de dicho complejo - Google Patents
Un complejo a base de acido ortosilicico biologicamente asimilable, que se presenta bajo una forma solida, estable y concentrada, y un proceso depreparacion de dicho complejoInfo
- Publication number
- AR026030A1 AR026030A1 ARP000105387A ARP000105387A AR026030A1 AR 026030 A1 AR026030 A1 AR 026030A1 AR P000105387 A ARP000105387 A AR P000105387A AR P000105387 A ARP000105387 A AR P000105387A AR 026030 A1 AR026030 A1 AR 026030A1
- Authority
- AR
- Argentina
- Prior art keywords
- complex
- presented
- stable
- solid
- biologically
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
Abstract
Un complejo a base de ácido ortosilícico biologicamente asimilable y un proceso de preparacion de dicho complejo. Este complejo se caracteriza en que elácido ortosilícico es acomplejado a un polipéptido y en que se presenta en forma solida, estable yconcentrada. Composiciones cosméticas y farmacéuticas, asícomo un complemento nutritivo que incluye el dicho complejo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9913062A FR2799758B1 (fr) | 1999-10-15 | 1999-10-15 | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026030A1 true AR026030A1 (es) | 2002-12-26 |
Family
ID=9551123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105387A AR026030A1 (es) | 1999-10-15 | 2000-10-13 | Un complejo a base de acido ortosilicico biologicamente asimilable, que se presenta bajo una forma solida, estable y concentrada, y un proceso depreparacion de dicho complejo |
Country Status (13)
Country | Link |
---|---|
US (1) | US6335457B1 (es) |
EP (1) | EP1092728B1 (es) |
JP (1) | JP4729161B2 (es) |
CN (1) | CN1202130C (es) |
AR (1) | AR026030A1 (es) |
AT (1) | ATE327257T1 (es) |
AU (1) | AU774668B2 (es) |
BR (2) | BR0004827B1 (es) |
DE (1) | DE60028152T2 (es) |
ES (1) | ES2262496T3 (es) |
FR (1) | FR2799758B1 (es) |
MX (1) | MXPA00010013A (es) |
PT (1) | PT1092728E (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9078465B2 (en) | 2002-03-20 | 2015-07-14 | Bio Minerals N.V. | Choline-silicic acid complex with osmolytes and divalent trace elements |
EP1371289A1 (en) * | 2002-03-20 | 2003-12-17 | Bio Minerals N.V. | Choline-silicic acid complex |
EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
US7887851B2 (en) * | 2004-06-07 | 2011-02-15 | Kao Corporation | Aromatase activator |
FR2911495B1 (fr) * | 2007-01-23 | 2014-06-27 | Oreal | Utilisation cosmetique d'associations de fer pour le soin de la peau. |
WO2009052090A2 (en) | 2007-10-15 | 2009-04-23 | 7 Oaks Pharmaceutical Corporation | Silicate containing compositions and methods of treatment |
GB0720423D0 (en) * | 2007-10-19 | 2007-11-28 | Univ Leuven Kath | Method for brewing beer |
WO2009127256A1 (en) * | 2008-04-17 | 2009-10-22 | Jisbrey, S.A | Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use |
WO2011010188A1 (en) * | 2009-07-23 | 2011-01-27 | Societe Anonyme Des Eaux Minerales D'evian "S.A.E.M.E" | A process for producing water enriched with natural orthosilicic acid |
GB0913255D0 (en) | 2009-07-30 | 2009-09-02 | Sisaf Ltd | Topical composition |
DE102010008981A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
EP2526954B1 (fr) | 2011-05-26 | 2014-08-13 | Dexsil Labs | Préparation biologique liquide contenant un complexe de silicium biodisponible, son procédé de production et son utilisation |
CN103113847B (zh) * | 2013-01-31 | 2015-04-01 | 重庆知德文化传播有限公司 | 竹制品或木制品粘合剂的制备工艺 |
GB201402672D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
EP3432860B1 (en) | 2016-03-22 | 2022-12-21 | Avicenna Nutraceutical, LLC | Hydrolyzed collagen compositions and methods of making thereof |
FR3049190B1 (fr) * | 2016-03-22 | 2019-07-26 | Societe Des Eaux De Source De Treignac | Eau concentree enrichie en acide orthosilicique naturel |
GB201904336D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
LU101518B1 (fr) | 2019-12-03 | 2021-06-07 | Intellectual Property Monitor | Complexe à base d'acide ortho-silicique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA972288A (en) * | 1971-01-20 | 1975-08-05 | Gyorgy Hajos | Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity |
NL9400189A (nl) * | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
JP3643994B2 (ja) * | 1995-12-18 | 2005-04-27 | コニカミノルタホールディングス株式会社 | インクジェット用記録媒体 |
FR2761075B1 (fr) | 1997-03-24 | 1999-06-11 | Seguin Marie Christine | Nouveaux composes a base de silicium biologiquement actifs et leurs applications therapeutiques |
-
1999
- 1999-10-15 FR FR9913062A patent/FR2799758B1/fr not_active Expired - Lifetime
-
2000
- 2000-10-05 DE DE60028152T patent/DE60028152T2/de not_active Expired - Lifetime
- 2000-10-05 PT PT00480090T patent/PT1092728E/pt unknown
- 2000-10-05 ES ES00480090T patent/ES2262496T3/es not_active Expired - Lifetime
- 2000-10-05 EP EP00480090A patent/EP1092728B1/fr not_active Expired - Lifetime
- 2000-10-05 AT AT00480090T patent/ATE327257T1/de active
- 2000-10-05 AU AU62492/00A patent/AU774668B2/en not_active Ceased
- 2000-10-12 JP JP2000311945A patent/JP4729161B2/ja not_active Expired - Fee Related
- 2000-10-12 US US09/686,882 patent/US6335457B1/en not_active Expired - Lifetime
- 2000-10-13 BR BRPI0004827-5B1A patent/BR0004827B1/pt not_active IP Right Cessation
- 2000-10-13 CN CNB001344129A patent/CN1202130C/zh not_active Expired - Fee Related
- 2000-10-13 MX MXPA00010013A patent/MXPA00010013A/es active IP Right Grant
- 2000-10-13 BR BRPI0004827A patent/BRPI0004827B8/pt not_active IP Right Cessation
- 2000-10-13 AR ARP000105387A patent/AR026030A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP4729161B2 (ja) | 2011-07-20 |
DE60028152T2 (de) | 2007-03-15 |
FR2799758A1 (fr) | 2001-04-20 |
EP1092728B1 (fr) | 2006-05-24 |
BR0004827A (pt) | 2001-05-22 |
ATE327257T1 (de) | 2006-06-15 |
AU774668B2 (en) | 2004-07-01 |
AU6249200A (en) | 2001-04-26 |
JP2001158798A (ja) | 2001-06-12 |
ES2262496T3 (es) | 2006-12-01 |
PT1092728E (pt) | 2006-09-29 |
MXPA00010013A (es) | 2005-02-17 |
BR0004827B1 (pt) | 2014-09-30 |
US6335457B1 (en) | 2002-01-01 |
EP1092728A2 (fr) | 2001-04-18 |
DE60028152D1 (de) | 2006-06-29 |
CN1202130C (zh) | 2005-05-18 |
FR2799758B1 (fr) | 2002-05-17 |
CN1298881A (zh) | 2001-06-13 |
EP1092728A3 (fr) | 2001-12-05 |
BRPI0004827B8 (pt) | 2022-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026030A1 (es) | Un complejo a base de acido ortosilicico biologicamente asimilable, que se presenta bajo una forma solida, estable y concentrada, y un proceso depreparacion de dicho complejo | |
DE60021541D1 (de) | Herstellung von hochloeslichen und stabilen mineralstoffergaenzungen | |
MX336939B (es) | Novedosos compuestos de triazolo pirimidina. | |
YU2003A (sh) | Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama | |
TW200513267A (en) | Collagen production enhancer and use and preparation thereof | |
HUP0204281A2 (hu) | Eljárás glukagonszerű peptid-1 vegyületek szolubiliázálására | |
DK1161452T3 (da) | Kovalent forbundne insulindimerer | |
MY135654A (en) | Process for the preparation of a dry pesticidal composition containing a water-soluble salt of glyphosate acid and a dicarboxylate component | |
YU7804A (sh) | Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova | |
DE50205571D1 (de) | Verfahren zur Herstellung von direkt tablettierbaren Beta-Mannit | |
ATE305771T1 (de) | Verfahren zur herstellung von vitaminpulvern | |
HUP0001034A2 (hu) | Stabil vizes lizinoldat | |
DE60236025D1 (de) | Pharmazeutische zusammensetzung enthaltend l-arginin | |
DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
RS63804A (en) | Stable salts of o-acetylsalicylic acid containing basic amino acids ii | |
NZ331083A (en) | Pharmaceutical preparations of cilansetron stabilized against racemization | |
AU6011001A (en) | Novel lhrh-antagonists, production and use thereof as medicament | |
SE9902742D0 (sv) | New pharmaceutical formultion | |
MC200019A1 (fr) | Complexe a base d'acide orthosilicique biologiquement assimilable se presentant sous forme solide stable et concentree et procede de preparation | |
AU2003290546A1 (en) | Base paints containing fatty acid-modified epoxy esters and/or fatty acid-modified alkyd resins, methods for the production thereof and their use | |
ATE356118T1 (de) | Moexipril-magnesium enthaltende arzneimittel | |
TR200200455T2 (tr) | İzotretinoin hazırlama işlemi | |
TH33236S (th) | ของเล่น | |
CY1112133T1 (el) | Σταθερο κρυσταλλικο μετα ασβεστιου αλας toy 5-meθyλo-(6s)-τετραϋδροφολικου οξεος | |
TH46245EX (th) | โคมไฟขั้วรับหลอดฟลูออเรสเซนต์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed, e.g., due to non-payment of fee |